BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines ...Middle East

PR Newswire - News
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
SHENZHEN, China, Aug. 2, 2021 /PRNewswire/ -- On July 30, Shenzhen Kangtai Biological Products Co., Ltd. (BIOKANGTAI) was approved by the Philippine Food and Drug Administration (PFDA) to launch the phase III clinical trial of its independently developed Inactivated COVID-19 Vaccine (Vero...

Hence then, the article about biokangtai covid 19 vaccine approved for phase iii clinical trial in the philippines was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News